Net Change in Cash
Gilead Sciences Net Change in Cash decreased by 100.0% to $0.00 in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 100.0%, from $4.96B to $0.00. Over 3 years (FY 2022 to FY 2025), Net Change in Cash shows a downward trend with a 230.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase suggests the company is accumulating liquidity, while a decrease indicates it spent more on investments, debt repayment, or operations than it generated in cash.
Detailed definition
This metric represents the total increase or decrease in a company's cash, cash equivalents, and restricted cash over a...
Peer comparison
This is a universal accounting standard used to reconcile the cash flow statement to the balance sheet across all industries and global peers.
cf_net_change_in_cashHistorical Data
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $828.00M | -$531.00M | -$1.04B | $443.00M | -$40.00M | $713.00M | -$476.00M | $768.00M | $1.00M | $380.00M | -$1.37B | -$1.95B | $2.26B | $4.96B | -$2.07B | -$2.78B | $2.19B | $0.00 |
| QoQ Change | — | -164.1% | -96.2% | +142.5% | -109.0% | >999% | -166.8% | +261.3% | -99.9% | >999% | -459.7% | -42.4% | +216.3% | +118.9% | -141.7% | -34.8% | +178.6% | -100.0% |
| YoY Change | — | — | — | -46.5% | +92.5% | — | +54.3% | +73.4% | +102.5% | -46.7% | -187.2% | -353.4% | >999% | >999% | -51.1% | -43.0% | -3.4% | -100.0% |
Net Change in Cash at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's net change in cash?
- Gilead Sciences (GILD) reported net change in cash of $0.00 in Q4 2025.
- How has Gilead Sciences's net change in cash changed year-over-year?
- Gilead Sciences's net change in cash decreased by 100.0% year-over-year, from $4.96B to $0.00.
- What is the long-term trend for Gilead Sciences's net change in cash?
- Over 3 years (2022 to 2025), Gilead Sciences's net change in cash has grown at a 230.1% compound annual growth rate (CAGR), from $74.00M to -$2.66B.
- What does net change in cash mean?
- The total change in the company's cash balance after accounting for all spending, earning, and investment activities.